Episode 50: Shutting the Door on Cancer Cells

Concarlo Therapeutics is developing a drug that could transform the way we treat cancer. In this episode, Co-founder, Chief Scientific Officer, and acting CEO of Concarlo Therapeutics, Dr. Stacy Blain,shares her journey of researching, testing and securing funding for a drug that kills off cancer cells.

Join us as we discuss:

  • Clinical grade manufacturing processes
  • FDA regulations and clinical trials
  • Cancer cell proliferation and necrosis

Leave a Reply